Medical News

RSS

Lupin grants Salix exclusive rights to its bioadhesive drug delivery technology for use with rifaximin

Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin’s proprietary technology.

5 Oct 2009

First edition: October 5, 2009

The continuing efforts to make progress on the nation's health overhaul are reflected in today's headlines, which highlight both politics and policies.

5 Oct 2009

NanoViricides completes a number of financing activities

NanoViricides, Inc. (the "Company"), announced today that it has completed a number of financing activities.

5 Oct 2009

NOAA awards $457,000 grant to track and manage outbreaks of toxic red tide algae

NOAA has awarded $457,000 in competitive grant funding to support three projects to better track and manage outbreaks of toxic red tide algae that threaten public health and New England's shellfish industry. The grant covers the first year of what will be multi-year projects. Anticipated to cost almost $1.5 million over the next three years, they will be carried out by the Woods Hole Oceanographic Institution, the University of Maine and the University of Texas.

5 Oct 2009

Jon O'Brien's statement on healthcare reform

"This Sunday, the United States Conference of Catholic Bishops holds its annual Respect Life Sunday. On this occasion, we would like to encourage the US bishops to also respect the truth. A recent publication by the USCCB, a brochure entitled Contraception: The Fine Print, and recent polls on healthcare reform prove that the bishops' desire to promote their own views on reproductive health leads them to play fast and loose with the truth.

5 Oct 2009

Trapeze Medical program to increase Medical-Grade Mobility solutions

Trapeze Networks, a Belden Brand, today announced an ambitious program, "Trapeze Medical," with the goal of extending the company's leadership in the international Wireless LAN healthcare market.

5 Oct 2009

GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgia

GlaxoSmithKline and XenoPort, Inc. today announced top-line results from a Phase II clinical trial evaluating GSK1838262/XP13512 (gabapentin enacarbil) in adult patients with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had a history of inadequate response to gabapentin doses of 1800 mg/day or higher.

5 Oct 2009

Surgeon Spotlight Series showcases interview with top orthopaedic surgeons

Allen Medical Systems, a Hill-Rom company, announces the second in its Surgeon Spotlight Series showcasing interviews with top orthopaedic surgeons. Carlos A. Guanche, M.D., managing partner at Southern California Orthopaedic Institute, is the featured surgeon and is recognized for his contributions in expanding the use of the Allen Intraoperative Arm Positioner for elbow fractures, scopes and clavicle repair procedures.

5 Oct 2009

Survey finds majority of Americans are at risk of heart disease due to their lifestyle factor

To help draw attention to National Child Health Day (today), the Preventive Cardiovascular Nurses Association (PCNA) has released findings from a new national consumer survey and launched a campaign to educate families about heart disease, the leading cause of death in the U.S.

5 Oct 2009

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

GVK Biosciences (GVK BIO), Asia’s leading integrated research services provider and Quantitative Solutions (QS), a modeling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases.

5 Oct 2009

Neurocrine Biosciences enters into an amendment to its facility lease agreement

Neurocrine Biosciences, Inc. announced today that the Company has entered into an amendment to its facility lease agreement. The amendment eliminates approximately 70,000 square feet of leased space.

5 Oct 2009

Genentech is again the world's most respected biopharmaceutical employer

Science annual survey of Top Employers polls employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries. Respondents to the web-based survey are asked to rate companies based on 23 driving characteristics, including financial strength, easy adaptation to change, and a research-driven environment.

5 Oct 2009

Prompt diagnosis and treatment for otitis media benefits organ transplant recipients

Organ transplant recipients benefit significantly when they are monitored and receive prompt diagnosis and treatment for otitis media, a common inner ear infection.

5 Oct 2009

Role of ISO 9000 in document review

Business Intelligence Associates, Inc. (BIA), an information management industry leader, today released "The Role of ISO 9000 in Document Review". This white paper highlights BIA's recent ISO 9001:2008 certification for its Document Review Services' Quality Management System.

5 Oct 2009

Allergan files declaratory relief action to allow it to share relavant information on BOTOX

Allergan, Inc. today filed a declaratory relief action in the United States District Court for the District of Columbia seeking a ruling that would allow Allergan to proactively share truthful and relevant information with the medical community to assist physicians in evaluating the risks and benefits of BOTOX (onabotulinumtoxinA) for certain “off-label” therapeutic uses.

5 Oct 2009

Theravance grants equity award to new employee

Theravance, Inc. today reported that an equity award was made to one new employee. Pursuant to Nasdaq Marketplace Rule 5635(c)(4), the equity award was granted under the Theravance, Inc. 2008 New Employee Equity Incentive Plan, which the Board of Directors of Theravance adopted to facilitate the granting of equity awards to new employees.

5 Oct 2009

Autistic patients have underlying medical disorders that are amenable to treatment

The National Children's Health Survey published results from a 2007 telephone survey in Pediatrics today in which 78,000 households in the US were asked if their child (ages 2-17) was known to "currently have autism, Asperger's Disorder, pervasive development disorder, or other autism spectrum disorder." The survey showed that 1% of children (one in 100) now have the disorder. Previous estimates from the CDC had reported a prevalence rate of one in 150.

5 Oct 2009

Oral Cancer Foundation initiates program to donate VELscope screening systems

The Oral Cancer Foundation recently initiated a program of donating VELscope® Oral Cancer Screening Systems to free clinics and others located in, and helping communities with, underserved populations.

5 Oct 2009

Genzyme named to the 2009 Dow Jones Sustainability World Index

Genzyme Corporation announced today that it was included on both the 2009 Dow Jones Sustainability World Index and North American Index. This marks the fifth consecutive year Genzyme has been named to the Dow Jones Sustainability North American Index and the first year the company has been named to the Dow Jones Sustainability World Index.

5 Oct 2009

Willow Breast Cancer Support Canada calls for national Metastatic Breast Cancer Awareness Day

Thousands of Canadian women with metastatic breast cancer and their loved ones are marking the first Canadian Metastatic Breast Cancer Awareness Day on October 13, urging Canadians to acknowledge them and delivering the message that "hope changes."

5 Oct 2009

Medical News

Lupin grants Salix exclusive rights to its bioadhesive drug delivery technology for use with rifaximin

First edition: October 5, 2009

NanoViricides completes a number of financing activities

NOAA awards $457,000 grant to track and manage outbreaks of toxic red tide algae

Jon O'Brien's statement on healthcare reform

Trapeze Medical program to increase Medical-Grade Mobility solutions

GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgia

Surgeon Spotlight Series showcases interview with top orthopaedic surgeons

Survey finds majority of Americans are at risk of heart disease due to their lifestyle factor

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

Neurocrine Biosciences enters into an amendment to its facility lease agreement

Genentech is again the world's most respected biopharmaceutical employer

Prompt diagnosis and treatment for otitis media benefits organ transplant recipients

Role of ISO 9000 in document review

Allergan files declaratory relief action to allow it to share relavant information on BOTOX

Theravance grants equity award to new employee

Autistic patients have underlying medical disorders that are amenable to treatment

Oral Cancer Foundation initiates program to donate VELscope screening systems

Genzyme named to the 2009 Dow Jones Sustainability World Index

Willow Breast Cancer Support Canada calls for national Metastatic Breast Cancer Awareness Day

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News